Vicks

Uveitis–Glaucoma–Hyphema Syndrome (UGHS) is a rare and complex ocular condition that involves inflammation of the uvea (Uveitis), increased intraocular pressure (Glaucoma), and bleeding in the anterior chamber of the eye (Hyphema).

Etiology[edit | edit source]

UGHS is typically associated with trauma or surgery, particularly intraocular surgeries such as cataract extraction. It can also occur spontaneously in rare cases. The exact cause of UGHS is not well understood, but it is thought to involve a combination of inflammatory, vascular, and mechanical factors.

Clinical Presentation[edit | edit source]

Patients with UGHS typically present with symptoms of ocular pain, redness, and decreased vision. On examination, there may be evidence of inflammation in the anterior chamber (Anterior Uveitis), elevated intraocular pressure, and blood in the anterior chamber.

Diagnosis[edit | edit source]

The diagnosis of UGHS is primarily clinical, based on the characteristic triad of uveitis, glaucoma, and hyphema. Additional tests such as ocular ultrasound, fluorescein angiography, and optical coherence tomography may be used to confirm the diagnosis and assess the extent of the disease.

Treatment[edit | edit source]

The treatment of UGHS is aimed at controlling the inflammation, reducing the intraocular pressure, and managing the hyphema. This may involve the use of topical and systemic medications, as well as surgical interventions in severe cases.

Prognosis[edit | edit source]

The prognosis of UGHS is variable, depending on the severity of the disease and the response to treatment. In some cases, the disease can lead to permanent vision loss.

References[edit | edit source]

Vicks Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.